Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 500 of 2228 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/18/18
End: 07/22/19
Due: 07/22/20
Phase: N/A
Priority: Normal
Start: 07/31/00
End: -
Due: -
Tolerability of BIBR 953 ZW IV and Bioavailability of BIBR 1048 Tablet and Solution in Healthy Males
Phase: N/A
Priority: Normal
Start: 01/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/21/21
End: 11/16/21
Due: 11/16/22
Phase: N/A
Priority: Normal
Start: 06/30/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/29/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/10/14
End: 06/13/16
Due: 06/13/17
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 10/31/14
Due: 10/31/15
Phase: N/A
Priority: Normal
Start: 10/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 06/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/99
End: -
Due: -
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)
Phase: N/A
Priority: Normal
Start: 08/24/21
End: 11/17/24
Due: 11/17/25